Agilent Technologies Stock News

This Infertility Testing And Treatment market report analyzed the market conditions of key region of the world including product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. The report introduced the new project SWOT analysis,

Kingfisher Capital LLC lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 2.7% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 29,836 shares of the medical research companys stock after purchasing an additional 793 shares during the period. Agilent Technologies comprises 1.2% of Kingfisher Capital LLCs holdings, []

DUBLIN--(BUSINESS WIRE)--The "Cannabis Testing Services Market Research Report by Type, End-user, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com''s offering. The Global Cannabis Testing Services Market size was estimated at USD 318.46 million in 2020, is expected to reach USD 373.58 million in 2021, and projected to grow at a CAGR of 17.64% reaching USD 844.28 million by 2026. Competitive Strategic Window The Competitive Stra

Latest Business Market Insights added report on North America Synthetic Biology Market research study by Market Digits offers detailed product outlook and elaborates market review till 2027. The market Study is segmented by key regions that is accelerating the marketization.

DUBLIN--(BUSINESS WIRE)--The "Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global oligonucleotide synthesis market exhibited strong growth during 2015-2020. Looking forward, the publisher expects the global oligonucleotide synthesis market to grow at a CAGR of 12.7% during the forecast period (2021-2026). Companies Mentioned Agilent Technologies Inc. Biolegio B.V

Nicoya''s Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) Nicoya Lifesciences, a global leader in digital proteomi

Ballentine Partners LLC raised its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 5.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,722 shares of the medical research companys stock after buying an additional 94 shares during the quarter. []

Marshall Financial Group LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 4.7% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 2,106 shares of the medical research companys stock after selling 104 shares during the quarter. Marshall Financial Group LLCs holdings in Agilent Technologies were worth []

Healthtech startup Nicoya Lifesciences has raised a healthy $20 million CAD Series A extension to assist in the continuing development and commercialization of its rapid, saliva-based COVID-19 antigen test. Whitecap Venture Partners led the round, which included participation from Agilent Technologies, Export Development Canada, BDC Capital, MaRS IAF, Garage Capital, and others. Their technology is being used every day by scientists who develop life-saving drugs and make key findings about common diseases that affect our lives. The round closed at the end of November. The new financing will go toward new features and functions for Atlas, Nicoyas main The post Nicoyas $20 million Series A extension enables continued development of COVID-19 test first appeared on BetaKit .

The Microinjector Market report is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference. Both conferences will be webcast. Details are included below. Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference Date: Jan. 6, 2022 Time: 11 a.m. ET/8 a.m. PT Presenting for Agilent: Mike McMullen, Agilent chief executive officer B

SANTA CLARA, Calif.--(BUSINESS WIRE)---- $A #Agilent--Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscri

CMI Research has released the latest version of its survey report on the Liquid Chromatography Mass Spectrometry (LCMS) Market, which includes 100+ market data tables, a pie chart, graphs and figures scattered over pages. The market is currently expanding its

Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx Key Companies in Next-Generation Sequencing Market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., QIAGEN, BGI, PerkinElmer Inc., Eurofins Scientific, Macrogen, Inc., PierianDx